These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3917658)

  • 1. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.
    Doty JE; Pitt HA; Porter-Fink V; Denbesten L
    Ann Surg; 1985 Jan; 201(1):76-80. PubMed ID: 3917658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
    Sitzmann JV; Pitt HA; Steinborn PA; Pasha ZR; Sanders RC
    Surg Gynecol Obstet; 1990 Jan; 170(1):25-31. PubMed ID: 2104681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intravenous fat and total parenteral nutrition on biliary physiology.
    Doty JE; Pitt HA; Porter-Fink V; DenBesten L
    JPEN J Parenter Enteral Nutr; 1984; 8(3):263-8. PubMed ID: 6429363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin increases bile acid synthesis with total parenteral nutrition but does not prevent stone formation.
    Dawes LG; Muldoon JP; Greiner MA; Bertolotti M
    J Surg Res; 1997 Jan; 67(1):84-9. PubMed ID: 9070187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition.
    Curran TJ; Uzoaru I; Das JB; Ansari G; Raffensperger JG
    J Pediatr Surg; 1995 Feb; 30(2):242-6; discussion 246-7. PubMed ID: 7738745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
    García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
    Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gallstone formation by sphincterotomy in the prairie dog: reversal by atropine.
    Hutton SW; Sievert CE; Vennes JA; Duane WC
    Gastroenterology; 1982 Jun; 82(6):1308-13. PubMed ID: 7067954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
    Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
    J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of parenteral nutrition on biliary calcium and bilirubin.
    Muller EL; Grace PA; Pitt HA
    J Surg Res; 1986 Jan; 40(1):55-62. PubMed ID: 3079846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel.
    Pauletzki JG; Xu QW; Shaffer EA
    Hepatology; 1995 Jul; 22(1):325-31. PubMed ID: 7601426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gallbladder bile acidification with long-term total parenteral nutrition.
    Dawes LG; Greiner M; Joehl RJ
    J Surg Res; 1999 Jan; 81(1):21-6. PubMed ID: 9889052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gallbladder absorption during gallstone formation: the roles of cholesterol saturated bile and gallbladder stasis.
    Roslyn JJ; Doty J; Pitt HA; Conter RL; Den Besten L
    Am J Med Sci; 1986 Aug; 292(2):75-80. PubMed ID: 3089012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ileal resection-induced gallstones: altered bilirubin or cholesterol metabolism?
    Pitt HA; Lewinski MA; Muller EL; Porter-Fink V; DenBesten L
    Surgery; 1984 Aug; 96(2):154-62. PubMed ID: 6463856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sincalide in patients with parenteral nutrition-associated gallbladder disease.
    Prescott WA; Btaiche IF
    Ann Pharmacother; 2004 Nov; 38(11):1942-5. PubMed ID: 15316105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?
    Messing B; Bories C; Kunstlinger F; Bernier JJ
    Gastroenterology; 1983 May; 84(5 Pt 1):1012-9. PubMed ID: 6403401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cisapride on total parenteral nutrition-associated cholestasis in rats.
    Zahavi I; Rosezki O; Stolkarts Y; Shamir R; Heckelman B; Marcus H; Dinari G
    Isr Med Assoc J; 2000 Feb; 2(2):91-3. PubMed ID: 10804925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained gallbladder stasis promotes cholesterol gallstone formation in the ground squirrel.
    Xu QW; Mantle M; Pauletzki JG; Shaffer EA
    Hepatology; 1997 Oct; 26(4):831-6. PubMed ID: 9328300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog.
    Hughes CA; Bates T; Dowling RH
    Gastroenterology; 1978 Jul; 75(1):34-41. PubMed ID: 122602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.
    Xu QW; Shaffer EA
    Gastroenterology; 1993 Oct; 105(4):1184-91. PubMed ID: 8405865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.